Similarly, PAR1-driven metastasis-associated gene expression in breast cancer and osteosarcoma cell lines can be impaired by treatment with MI-2 and the suicide inhibitor z-VRPR-fmk [83]. This evidence concerns the gene F2R and osteosarcoma.